# David M. Weitzman, M.D. – FDA Inspection, Jan 26, 2024

Source: https://www.keypedia.com/records/fda_inspections/david-m-weitzman-md/582566c8-a5d1-4935-91ef-ac6bf7ee6fde
Source feed: FDA_Inspections

> FDA inspection 1228232 of David M. Weitzman, M.D., January 26, 2024. Classification: Voluntary Action Indicated (VAI). 1 citation under 21 CFR part 312.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1228232
- Company Name: David M. Weitzman, M.D.
- Inspection Date: 2024-01-26
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 1

## Related Officers

- [Investigator](https://www.keypedia.com/people/deborah-a-greco/38e393b5-55c4-461c-a0b0-4937e0cbec37)

Company: https://www.keypedia.com/companies/david-m-weitzman-md/9306629a-af29-4035-aed8-528c2a1c60dc

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c